Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2008-05-30
2010-11-09
Olson, Eric S (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S027000, C514S032000, C536S017400
Reexamination Certificate
active
07829542
ABSTRACT:
Methods and compositions for treating or ameliorating diseases and other conditions, such as infectious diseases, autoimmune diseases and allergies are provided. The methods employ cyclic AGPs for selectively stimulating immune responses in animals and plants.
REFERENCES:
patent: 4987237 (1991-01-01), Myers et al.
patent: 5508310 (1996-04-01), Rhodes
patent: 6113918 (2000-09-01), Johnson et al.
patent: 6221388 (2001-04-01), Hersch et al.
patent: 6303347 (2001-10-01), Johnson et al.
patent: 6355257 (2002-03-01), Johnson et al.
patent: 6525028 (2003-02-01), Johnson et al.
patent: 6531453 (2003-03-01), Taniguchi et al.
patent: 6911434 (2005-06-01), Baldridge et al.
patent: 7129219 (2006-10-01), Johnson et al.
patent: 7501399 (2009-03-01), Johnson et al.
patent: 2002/0115624 (2002-08-01), Behar et al.
patent: 0004147 (2001-04-01), None
patent: WO 98/50399 (1998-11-01), None
patent: WO 00/11010 (2000-03-01), None
patent: WO 01/70209 (2001-09-01), None
patent: WO 01/90129 (2001-11-01), None
patent: WO 01/90129 (2001-11-01), None
patent: WO 02/12258 (2002-02-01), None
patent: WO 03/065806 (2003-08-01), None
patent: WO 03/066065 (2003-08-01), None
Merriam-Webster's Collegiate Dictionary, published 1998 by Merriam-Webster, Incorporated, pp. 924 and 935.
Dorland, I.,Dorland's Illustrated Medical Dictionary, 30th Edition, Philadelphia, Elsevier, 2003.
Johnson, David A. et al.; “Synthesis and Biological Evaluation of a New Class of Vaccine Adjuvants: Aminoalkyl Glucosaminide 4-Phosphates (AGPs)”; 1999,Bioorganic&Medicinal Chemistry Letters, vol. 9, pp. 2273-2278.
Paradisi et al., “Streptococcus pneumoniae as an agent of nosocomal infection: treatment in the era of penicillin-resistant strains,” 2001, Clinical Microbiology and Infection, vol. 7, Suppl. 4, pp. 34-42.
Passalacqua et al., “Allergen-Specific Sublingual Immunotherapy for Respiratory Allergy,” 2001, BioDrugs, vol. 15, No. 8, pp. 509-519.
Quesniaux, Valerie FJ et al.; “Toll-like receptors: emerging targets of immunomodulation”; 2004,Expert Opinionvol. 14, No. 1, pp. 85-100.
Baldridge Jory R.
Cluff Christopher W.
Johnson David A.
Corixa Corporation
Olson Eric S
Townsend and Townsend / and Crew LLP
LandOfFree
Prophylactic and therapeutic treatment of infectious and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prophylactic and therapeutic treatment of infectious and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prophylactic and therapeutic treatment of infectious and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4181674